Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Byrne

Showing results (1-10 of 457) with videos related to

Pageof 46
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 2, 2010
Fatty liver: role of inflammation and fatty acid nutritionChristopher D Byrne
Diabetes, Obesity & Metabolism|June 3, 2004
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetesChristopher D Byrne
Diabetic Medicine : a Journal of the British Diabetic Association|July 5, 2022
Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'Christopher D Byrne
ACP Journal Club|January 20, 2005
Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetesChristopher D Byrne
The Proceedings of the Nutrition Society|May 15, 2013
Ectopic fat, insulin resistance and non-alcoholic fatty liver diseaseChristopher D Byrne
Clinical Science (London, England : 1979)|November 11, 2009
Hypoxia and non-alcoholic fatty liver diseaseChristopher D Byrne
Gastroenterology & Hepatology|November 18, 2022
The Relationship Between Nonalcoholic Fatty Liver Disease and Chronic Kidney DiseaseChristopher D Byrne
Journal of Hepatology|April 29, 2015
NAFLD: a multisystem diseaseChristopher D Byrne, Giovanni Targher
Molecular Aspects of Medicine|March 17, 2018
Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of actionEleonora Scorletti, Christopher D Byrne
Journal of Hepatology|February 16, 2020
NAFLD as a driver of chronic kidney diseaseChristopher D Byrne, Giovanni Targher
Pageof 46

Showing results (1-10 of 457) with videos related to

Sort By:
Pageof 46
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 2, 2010
Fatty liver: role of inflammation and fatty acid nutritionChristopher D Byrne
Diabetes, Obesity & Metabolism|June 3, 2004
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetesChristopher D Byrne
Diabetic Medicine : a Journal of the British Diabetic Association|July 5, 2022
Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'Christopher D Byrne
ACP Journal Club|January 20, 2005
Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetesChristopher D Byrne
The Proceedings of the Nutrition Society|May 15, 2013
Ectopic fat, insulin resistance and non-alcoholic fatty liver diseaseChristopher D Byrne
Clinical Science (London, England : 1979)|November 11, 2009
Hypoxia and non-alcoholic fatty liver diseaseChristopher D Byrne
Gastroenterology & Hepatology|November 18, 2022
The Relationship Between Nonalcoholic Fatty Liver Disease and Chronic Kidney DiseaseChristopher D Byrne
Journal of Hepatology|April 29, 2015
NAFLD: a multisystem diseaseChristopher D Byrne, Giovanni Targher
Molecular Aspects of Medicine|March 17, 2018
Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of actionEleonora Scorletti, Christopher D Byrne
Journal of Hepatology|February 16, 2020
NAFLD as a driver of chronic kidney diseaseChristopher D Byrne, Giovanni Targher
Pageof 46